Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms|Neoplasm Metastasis
Sponsor: Peking University Cancer Hospital & Institute